ABT-267
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for ABT-267, covering 2012-01-24 to 2017-10-27. Get the full timeline:
Most recent: Clinical Trial Update: ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Treatment-Naïve and Treatment-Experienced, Non-Cirrhotic Asian Adults With Subgenotype 1b Chronic Hepatitis C Virus (HCV) Infection [Phase 3]